BFA
ETRM

BlackRock Fund Advisors’s EnteroMedics Inc. ETRM Stock Holding History

BlackRock Fund Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$0 Buy
25
+7
+39% +$37 ﹤0.01% 4344
2016
Q3 		$0 Buy
18
+2
+13% +$27 ﹤0.01% 4384
2016
Q2 		$0 Sell
16
-141
-90% -$6.46K ﹤0.01% 4427
2016
Q1 		$11K Sell
157
-12
-7% -$970 ﹤0.01% 3975
2015
Q4 		$23K Buy
169
+10
+6% +$2.07K ﹤0.01% 3952
2015
Q3 		$43K Sell
159
-4
-2% -$1.28K ﹤0.01% 3853
2015
Q2 		$106K Buy
163
+20
+14% +$23K ﹤0.01% 3726
2015
Q1 		$138K Sell
143
-10
-7% -$12.1K ﹤0.01% 3570
2014
Q4 		$228K Buy
153
+11
+8% +$14.9K ﹤0.01% 3454
2014
Q3 		$184K Buy
142
+12
+9% +$17.6K ﹤0.01% 3505
2014
Q2 		$212K Buy
130
+4
+3% +$7.48K ﹤0.01% 3469
2014
Q1 		$241K Buy
126
+15
+14% +$35.5K ﹤0.01% 3416
2013
Q4 		$237K Buy
111
+5
+5% +$8.06K ﹤0.01% 3396
2013
Q3 		$139K Buy
106
+8
+8% +$9.31K ﹤0.01% 3493
2013
Q2 		$117K Buy
+98
New +$103K ﹤0.01% 3490

Other funds holding ETRM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

BlackRock Fund Advisors's ETRM Position: Q4 2016 in Review

BlackRock Fund Advisors increased its EnteroMedics Inc. (ETRM) stake by 39% in Q4 2016, buying an estimated $37 and bringing the position to 25 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4344.

BlackRock Fund Advisors first reported a position in ETRM in Q2 2013 and has held it in 15 quarters since. The position peaked at $241K in Q1 2014. 18 funds tracked by Wall St. Rank hold ETRM as of Q4 2016.

  • BlackRock Fund Advisors held 25 shares of EnteroMedics Inc. worth $0 as of Q4 2016.
  • BlackRock Fund Advisors bought 7 EnteroMedics Inc. shares in Q4 2016, an estimated $37.
  • EnteroMedics Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4344 holding.
  • BlackRock Fund Advisors first reported a position in EnteroMedics Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's EnteroMedics Inc. position peaked at $241K in Q1 2014.
  • 18 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.